To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC50317 | γ-AA peptide P6 (Cyclic γ-AA Peptide 6) Featured |
γ-AA peptide P6 (Cyclic γ-AA P6) is a potent activator of E6 associated protein (E6AP). γ-AA peptide P6 can stimulate the self-ubiquitination of E6AP and E6AP-catalyzed substrate ubiquitination in reconstituted reactions in vitro. γ-AA peptide P6 can also enhance the ubiquitination of E6AP substrates in the cell and accelerate their degradation by the proteasome.
More description
|
|
| DCC1108 | Bpn-14136 Featured |
Novel RBP4 antagonist with good in vitro potency and selectivity and optimal rodent pharmacokinetic (PK) and pharmacodynamic (PD) characteristics
More description
|
|
| DC21463 | CI-976 Featured |
CI-976 (PD 128042) is a potent, selective, orally bioavailable inhibitor of ACAT-1 (Acetyl-CoA acetyltransferase 1) with IC50 of 73 nM.
More description
|
|
| DC42731 | FTY720(8)-Phosphate Featured |
A sphingosine 1-phosphate (S1PR) receptor agonist
More description
|
|
| DC11639 | Shield-1 Featured |
Shield-1 is a cell-permeable FKBP ligand that is designed to protect an otherwise unstable protein domain from degradation; binds tightly to FKBP, induces rapid and processive degradation of the LID domain.
More description
|
|
| DCC3720 | Nrf2-activator Featured |
Nrf2-Activator is a potent Nrf-2 activator.
More description
|
|
| DC43088 | GSK'843 Featured |
Selective RIP3 kinase inhibitor
More description
|
|
| DC12585 | TB47 Featured |
QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M. tuberculosis clinical isolates.
More description
|
|
| DC47470 | SBP-3264 Featured |
SBP-3264 is a valuable chemical probe for understanding the roles of STK3 and STK4 in acute myeloid leukemia (AML).
More description
|
|
| DC34482 | Dihydroresveratrol Featured |
Dihydroresveratrol is an SIRT1 activator. It is a primary metabolite of resveratrol.
More description
|
|
| DC43788 | 10-Hydroxycanthin-6-one Featured |
10-Hydroxycanthin-6-one is an antileukemic canthin-6-one alkaloid from Brucea antidysenterica. Antitumor agent.
More description
|
|
| DC42984 | 9-Hydroxycanthin-6-one Featured |
9-Hydroxycanthin-6-one is an alkaloid compound. 9,10-Dimethoxycanthin-6-one exhibits NF-κB inhibitory effects with an IC50 of 3.8 μM.
More description
|
|
| DC28295 | 9-Methoxycanthin-6-one Featured |
9-Methoxycanthin-6-one, a canthin-6-one alkaloid, is present in intact plant parts and in callus tissues of different explants. 9-Methoxycanthin-6-one shows anti-tumor activity.
More description
|
|
| DC43524 | Canthin-6-one Featured |
Canthin-6-one displays a wide range of biological activities, such as antimycobacterial activity.
More description
|
|
| DC72076 | AZD5462 Featured |
AZD5462 is a selective oral allosteric relaxin family peptide receptor 1 (RXFP1) agonist with pEC50 of 7.8. AZD5462 has better kinetic solubility and shows much improved metabolic stability compared to AZ7976 in vitro.
More description
|
|
| DCB-029 | Anemoside B4 Featured |
Pulchinenoside B4 is a triterpenoid glycoside that inhibits cisplatin-induced apoptosis, increases in reactive oxygen species (ROS) production, and decreases in superoxide dismutase (SOD) and catalase activities. Pulchinenoside B4 also prevents increases in plasma blood urea nitrogen (BUN) and creatinine levels -- markers of kidney injury.
More description
|
|
| DC21056 | GMI-1271 Featured |
A novel specific glycomimetic E-Selectin antagonist with Kd of 0.46 uM, IC50 of 1.75 uM.
More description
|
|
| DC45418 | Lipase Substrate Featured |
Lipase Substrate is a substrate of lipase to detect activity.
More description
|
|
| DC74615 | BC-05 |
BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research.
More description
|
|
| DC74614 | Ucasareotide dasaroxetan |
Ucasareotide dasaroxetan (SarTATE) is diagnostic agent with antineoplastic effect.
More description
|
|
| DC74613 | Tegomil fumarate |
Tegomil fumarate is an immunomodulator.
More description
|
|
| DC74611 | Civorebrutinib |
Civorebrutinib (WS-413) is a Bruton's tyrosine kinase inhibitor with antineoplastic effect.
More description
|
|
| DC74610 | XY-52 |
XY-52 (Compound 32) is a Stimulation-2 (ST2) inhibitor, with an IC50 value of 5.68 μM in AlphaLISA assay, and 4.59 μM in HEK-Blue assay. XY-52 increases proinflammatory T-cell proliferation. XY-52 reduces the plasma sST2 and IFNγ biomarkers in the graft versus host disease (GVHD) mice model.
More description
|
|
| DC74609 | 9-Deazaguanine |
9-Deazaguanine is a nucleoside analog with potent inhibitory activity against purine nucleoside phosphorylase (PNP).
More description
|
|
| DC74607 | Sucantomotide |
Sucantomotide is an immunological agent for active immunization (antineoplastic).
More description
|
|
| DC74606 | Enavermotide |
Enavermotide (UCP2) is an immunological agent for active immunization (antineoplastic).
More description
|
|
| DC74602 | Potassium clavulanate cellulose |
Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) is a mixture of potassium clavulanate and cellulose, is a bacterial β-lactamase inhibitor. Potassium clavulanate with the combination of amoxicillin can be used for the research of different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.
More description
|
|
| DC74601 | Solutol HS-15 |
Solutol HS-15(Polyethylene glycol 12-hydroxystearate) is a Macrogol 15 hydroxy stearate, which improves permeability by disrupting the membrane structure/fluidity change.
More description
|
|
| DC74599 | Ethotoin |
Ethotoin (Peganone) is a hydantoin derivative and an orally active anticonvulsant agent. It also exerts an antiepileptic effect and can be used in epilepsy research.
More description
|
|
| DC74597 | 3,3-Dimethyl-1-butanol |
3,3-Dimethyl-1-butanol (Neohexanol) is an orally active inhibitor of trimethylamine (TMA) and trimethylamine N-oxide (TMAO). 3,3-dimethyl-1-butanol negatively inhibits the signalling pathways of p65 NF-κB and TGF-β1/Smad3. 3,3-dimethyl-1-butanol has potential applications in cardiovascular disease (CVD).
More description
|
|